Metraipolis › archive › dc_1fc7eebc88f7
Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World… — Europe PMC PMID:42645346
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42645346
- DOI
- 10.3390/curroncol33080441
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T20:30:39.948Z
- SHA-256 of the archived text
07651e726bef33cc0ae4bba10a1c83a88ca44a0e490e15232c5e8fbc4e6b0e8b- Stable URL of this page
https://metraipolis.com/documento/dc_1fc7eebc88f7
How to cite
Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World… — Europe PMC PMID:42645346 — Europe PMC (en), https://europepmc.org/article/MED/42645346 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fc7eebc88f7 (Metraipolis archive dc_1fc7eebc88f7, sha256 07651e726bef33cc0ae4bba10a1c83a88ca44a0e490e15232c5e8fbc4e6b0e8b)
BibTeX
@misc{dc1fc7eebc88f7,
title = {Prognostic Value of the Systemic Immune-Inflammation Index in Advanced Endometrial Cancer Treated with Pembrolizumab-Lenvatinib: A Retrospective Real-World… — Europe PMC PMID:42645346},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42645346},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fc7eebc88f7; sha256 07651e726bef33cc0ae4bba10a1c83a88ca44a0e490e15232c5e8fbc4e6b0e8b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645346. Agents can read the archived copy with the MCP tool read_document.